Gossamer Bio, Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2018 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Gossamer Bio, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2018 to Q4 2024.
  • Gossamer Bio, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2024 was $689K, a 21.6% decline year-over-year.
  • Gossamer Bio, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2024 was $4.28M, a 8.68% increase year-over-year.
  • Gossamer Bio, Inc. annual Nonoperating Income (Expense) for 2024 was $4.28M, a 8.68% increase from 2023.
  • Gossamer Bio, Inc. annual Nonoperating Income (Expense) for 2023 was $3.94M.
  • Gossamer Bio, Inc. annual Nonoperating Income (Expense) for 2022 was -$10.8M, a 39.7% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $4.28M $689K -$190K -21.6% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-13
Q3 2024 $4.47M $1.98M +$1.5M +312% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $2.97M $1.58M -$2.22M -58.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $5.2M $31K +$1.25M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $3.94M $879K +$2.29M Oct 1, 2023 Dec 31, 2023 10-K 2025-03-13
Q3 2023 $1.66M $482K +$3.82M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$2.17M $3.8M +$6.4M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$8.57M -$1.22M +$2.22M +64.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 -$10.8M -$1.41M +$3.22M +69.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-03-13
Q3 2022 -$14M -$3.34M +$1.24M +27.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$15.2M -$2.59M +$1.64M +38.8% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$16.9M -$3.44M +$996K +22.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$17.9M -$4.62M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$4.58M -$340K -8.01% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$4.24M -$2.71M -177% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$4.44M -$5.33M -597% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 -$3.79M -$4.24M -$5.73M -386% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $1.94M -$1.53M -$3.38M -183% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $5.32M $893K -$513K -36.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $5.83M $1.09M +$76K +7.5% Oct 1, 2019 Dec 31, 2019 10-K 2020-03-24
Q3 2019 $5.76M $1.49M +$864K +139% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $4.89M $1.85M +$1.55M +517% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $3.34M $1.41M +$1.32M +1480% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $2.02M $1.01M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-24
Q3 2018 $622K Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $300K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $89K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.